BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. ✅
International journal of clinical and experimental pathology (Int J Clin Exp Pathol ) Vol: 8 Issue 5 Pages: 5217-23 Pub: 2015 Epub: 2015 May 1 Authors Peng L , Kang S , Yin Z , Jia R , Song X , Li L , Li Z , Zou Y , Liang X , Li L , He C , Ye G , Yin L , Shi F , Lv C , Jing B , |
|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. ✅
Go to Publication ✅
Archives of Iranian medicine (Arch Iran Med ) Vol: 19 Issue 3 Pages: 197-203 Pub: 2016 Mar Epub: Authors Cao Y , Pan Q , Cai W , Shen F , Chen GY , Xu LM , Fan JG , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
The Effects of Berberine on the Gut Microbiota in Apc <sup>min/+</sup> Mice Fed with a High Fat Diet. ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 23 Issue 9 Pages: Pub: 2018 Sep 8 Epub: 2018 Sep 8 Authors Wang H , Guan L , Li J , Lai M , Wen X , |
|
|
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671 Pub: 2016 Jun 10 Epub: 2016 Jun 10 Authors Alolga RN , Fan Y , Chen Z , Liu LW , Zhao YJ , Li J , Chen Y , Lai MD , Li P , Qi LW , |
|
|
Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 1210 Pub: 2020 Epub: 2020 Aug 31 Authors Li L , Cui H , Li T , Qi J , Chen H , Gao F , Tian X , Mu Y , He R , Lv S , Chu F , Xu B , Wang P , Lei H , Xu H , Wang C , |
|
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
|
Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis. ✅
Go to Publication ✅
In vivo (Athens, Greece) (In Vivo ) Vol: 37 Issue 5 Pages: 2105-2127 Pub: 2023 Sep-Oct Epub: Authors Chen D , Xiong J , Chen G , Zhang Z , Liu Y , Xu J , Xu H , |
|
|
Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens. ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 24 Issue 24 Pages: Pub: 2023 Dec 9 Epub: 2023 Dec 9 Authors Wang C , Yang Y , Chen J , Dai X , Xing C , Zhang C , Cao H , Guo X , Hu G , Zhuang Y , |
|
|
Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 131 Issue Pages: 110669 Pub: 2020 Nov Epub: 2020 Sep 13 Authors Yao Y , Chen H , Yan L , Wang W , Wang D , |
|
|
Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 131 Issue Pages: 110669 Pub: 2020 Nov Epub: 2020 Sep 13 Authors Yao Y , Chen H , Yan L , Wang W , Wang D , |
|
|
Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats. ✅
Go to Publication ✅
Pharmacognosy magazine (Pharmacogn Mag ) Vol: 13 Issue 52 Pages: 677-682 Pub: 2017 Oct-Dec Epub: 2017 Nov 13 Authors Li D , Zheng J , Hu Y , Hou H , Hao S , Liu N , Wang Y , |
|
|
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. ✅
Go to Publication ✅
Clinical and translational medicine (Clin Transl Med ) Vol: 10 Issue 4 Pages: e112 Pub: 2020 Aug Epub: 2020 Aug 13 Authors Li S , Wang N , Tan HY , Chueng F , Zhang ZJ , Yuen MF , Feng Y , |
|
|
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. ✅
Go to Publication ✅
Clinical and translational medicine (Clin Transl Med ) Vol: 10 Issue 4 Pages: e112 Pub: 2020 Aug Epub: 2020 Aug 13 Authors Li S , Wang N , Tan HY , Chueng F , Zhang ZJ , Yuen MF , Feng Y , |
|
|
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ✅
Go to Publication ✅
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 7 Issue 1 Pages: 36 Pub: 2021 Apr 16 Epub: 2021 Apr 16 Authors Li X , Su C , Jiang Z , Yang Y , Zhang Y , Yang M , Zhang X , Du Y , Zhang J , Wang L , Jiang J , Hong B , |
|
|
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ✅
Go to Publication ✅
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 7 Issue 1 Pages: 36 Pub: 2021 Apr 16 Epub: 2021 Apr 16 Authors Li X , Su C , Jiang Z , Yang Y , Zhang Y , Yang M , Zhang X , Du Y , Zhang J , Wang L , Jiang J , Hong B , |
|
|
Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 107 Issue Pages: 1556-1563 Pub: 2018 Nov Epub: 2018 Sep 5 Authors Shi Y , Hu J , Geng J , Hu T , Wang B , Yan W , Jiang Y , Li J , Liu S , |
|
|
Effect of berberine on spleen transcriptome and gut microbiota composition in experimental autoimmune uveitis. ✅
Go to Publication ✅
International immunopharmacology (Int Immunopharmacol ) Vol: 81 Issue Pages: 106270 Pub: 2020 Apr Epub: 2020 Feb 7 Authors Du Z , Wang Q , Huang X , Yi S , Mei S , Yuan G , Su G , Cao Q , Zhou C , Wang Y , Kijlstra A , Yang P , |
|
|
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. ✅
Go to Publication ✅
Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070 Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L , |
|
|
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. ✅
Go to Publication ✅
Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070 Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L , |
|
|
Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. ✅
Go to Publication ✅
Genome medicine (Genome Med ) Vol: 13 Issue 1 Pages: 125 Pub: 2021 Aug 9 Epub: 2021 Aug 9 Authors Ming J , Yu X , Xu X , Wang L , Ding C , Wang Z , Xie X , Li S , Yang W , Luo S , He Q , Du Y , Tian Z , Gao X , Ma K , Fang Y , Li C , Zhao J , Wang X , Ji Q , |
|
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. ✅
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
